Loading organizations...
HM Capital is an independent commercial mortgage banking and capital advisory firm based in Tulsa, Oklahoma, with additional offices in Oklahoma City and Fayetteville, Arkansas, specializing in customized debt and equity financing for income-producing real estate across the U.S. The firm leverages a national network of institutional capital sources to provide solutions for commercial and multifamily real estate developers and investors. Since 2001, HM Capital has financed over $1.6 billion in real estate projects, establishing itself as a prominent independent firm in its local markets. It is a founding member of Strategic Alliance Mortgage (SAM), a network of independent commercial real estate investment banking firms. HM Capital was founded in 1977 as Holliday Mortgage Corporation by Jim Holliday.
Key people at HM Capital.
HM Capital has 5 tracked investments across 5 companies. The latest tracked deal is $50.0M Series B in OncoC4 in October 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 2, 2025 | OncoC4 | $50.0M Series B | GBA Fund | 3E Bioventures Capital, Kaitai Capital |
| Aug 22, 2022 | Porton Advanced Solutions | $80.0M Series B | China Merchants Capital, Merchant Health | CS Capital, Fosun Health Capital, Gortune Investment, Momentum Ventures, Porton Pharma Solutions, Ruilian Xingshan Capital, Sdictk |
| Mar 8, 2022 | Osteal Therapeutics | $30.0M Series B | HM Capital | — |
| Jan 1, 2022 | GenFleet Therapeutics | $78.5M Series C | Zeng Zhiqiang | Baidu Ventures, CDH Investments, Cherami Investment Group, Dyee Capital, Lake Bleu Capital, Panlin Capital, Qiaojing Eastern Investment, Shanjin Asset, Suxin Venture Capital |
| Feb 12, 2021 | 3-V Biosciences | $80.0M Other Equity | — | Altium Capital, Ascletis, Invus, Beth Seidenberg, Matt McAviney, PFM Health Sciences, Rock Springs Capital |
Key people at HM Capital.
